MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Lymphomahub.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Lymphomahub.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Lymphomahub.com most likely does not offer any adult content.
Popular pages
-
The 5th edition of the World Health Organization classification of hematolymphoid tumors: lymphoid
The WHO is set to release the 5th version of its classification of hematolymphoid tumors: lymphoid neoplasms later this year. Here, we summarize the key points relating to DLBCL.
-
Lymphoma and COVID-19: Management guidelines
Throughout the COVID-19 pandemic, healthcare has faced a myriad of challenges, including restrictions on cancer therapies and other medical resources.
-
Bispecific antibodies for patients with R/R B-cell lymphoma: Latest updates from phase II trials
The two ongoing phase II trials showed that both epcoritamab and glofitamab achieved high CR rates in highly refractory patients with B-cell lymphoma. The responses remained consistent across the key ...
-
EBMT 2022: What are the highlights for the treatment of lymphoma?
During the 2022 EBMT Annual Meeting, the Lymphoma Hub was pleased to speak with Marek Trněný, Charles University Prague, CZ. We asked, EBMT 2022: What are the highlights for the treatment of lymphom...
-
EHA2022 abstracts: What's hot in lymphoma and CLL?
To help navigate the exciting content being presented at the EHA2022 Congress, the Lymphoma Hub Steering Committee members have provided their recommendations for the top abstracts to look out for in ...
-
The Scientific Education Support Team | Lymphoma Hub
Online lymphoma resource for healthcare professionals, providing information, news & support relating to lymphoma, Hodgkin & non Hodgkin disease